Catalyst Pharmaceuticals Inc (CPRX)
15.92
-0.35
(-2.15%)
USD |
NASDAQ |
Mar 28, 16:00
15.92
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap: 1.876B for March 28, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 28, 2024 | 1.876B |
March 27, 2024 | 1.918B |
March 26, 2024 | 1.856B |
March 25, 2024 | 1.869B |
March 22, 2024 | 1.854B |
March 21, 2024 | 1.959B |
March 20, 2024 | 1.993B |
March 19, 2024 | 1.932B |
March 18, 2024 | 1.895B |
March 15, 2024 | 1.894B |
March 14, 2024 | 1.908B |
March 13, 2024 | 1.959B |
March 12, 2024 | 1.909B |
March 11, 2024 | 1.898B |
March 08, 2024 | 1.915B |
March 07, 2024 | 1.961B |
March 06, 2024 | 1.869B |
March 05, 2024 | 1.918B |
March 04, 2024 | 1.967B |
March 01, 2024 | 2.005B |
February 29, 2024 | 1.889B |
February 28, 2024 | 1.716B |
February 27, 2024 | 1.691B |
February 26, 2024 | 1.671B |
February 23, 2024 | 1.672B |
Date | Value |
---|---|
February 22, 2024 | 1.655B |
February 21, 2024 | 1.632B |
February 20, 2024 | 1.642B |
February 16, 2024 | 1.667B |
February 15, 2024 | 1.654B |
February 14, 2024 | 1.605B |
February 13, 2024 | 1.569B |
February 12, 2024 | 1.624B |
February 09, 2024 | 1.624B |
February 08, 2024 | 1.572B |
February 07, 2024 | 1.569B |
February 06, 2024 | 1.617B |
February 05, 2024 | 1.574B |
February 02, 2024 | 1.601B |
February 01, 2024 | 1.696B |
January 31, 2024 | 1.693B |
January 30, 2024 | 1.736B |
January 29, 2024 | 1.699B |
January 26, 2024 | 1.680B |
January 25, 2024 | 1.708B |
January 24, 2024 | 1.716B |
January 23, 2024 | 1.755B |
January 22, 2024 | 1.781B |
January 19, 2024 | 1.712B |
January 18, 2024 | 1.728B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
269.90M
Minimum
Mar 16 2020
2.216B
Maximum
Jan 13 2023
872.77M
Average
613.98M
Median
Jun 28 2021
Market Cap Benchmarks
Applied Therapeutics Inc | 720.03M |
Sarepta Therapeutics Inc | 12.15B |
PTC Therapeutics Inc | 2.227B |
Voyager Therapeutics Inc | 504.45M |
Crinetics Pharmaceuticals Inc | 3.640B |
Market Cap Related Metrics
PE Ratio | 26.10 |
PS Ratio | 4.478 |
Price to Book Value | 4.838 |
Price to Free Cash Flow | 28.82 |
Price | 15.92 |
Earnings Yield | 3.83% |
Operating PE Ratio | 20.54 |
Normalized PE Ratio | 26.10 |